Grants and Contributions:

Grant or Award spanning more than one fiscal year (2017-2018 to 2018-2019).

Cancer is the leading cause of death in Canada, and skin cancer is one of the common types of the disease.x000D
Fortunately, the detection of skin cancer is comparatively easy since in most cases the symptoms can bex000D
recognized on visual inspection of the skin. However, limited access to dermatologists and long wait times forx000D
routine consultation are the main constraints for early diagnosis of skin cancer, which is key to a successfulx000D
treatment. To address this problem, MetaOptima has developed MoleScope, a low-cost, smart skin imagingx000D
system. The MoleScope has an optical setup that attaches to a smartphone to acquire high-quality magnifiedx000D
images. Using a MoleScope, patients can monitor and track changes in their skin moles and obtain rapidx000D
evaluations of cancer risk by sending the images of suspect skin lesions to their dermatologist.x000D
The aim of this project is to modify the current successful optical setup of the MoleScope device to improvex000D
the quality and resolution of the images by suppressing optical aberrations and stray reflections. We will alsox000D
design and develop a new optical magnifier system with a choice of magnification including a higherx000D
magnification capability. The result of this project will allow the MoleScope to be used to examine a broaderx000D
range of medically relevant structures with improved accuracy.